| AYTU BIOPHARMA, INC | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2014-Nov-30 | 2014-May-31 | 2014-Feb-28 | 2013-Nov-30 | ||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q1-FY2015 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | ||||||
| Price to Sales | .35x | .28x | .20x | .11x | .16x | .23x | .24x | .20x | .18x | .10x | .05x | .08x | .11x | .11x | .25x | .36x | .47x | 1.07x | 1.93x | 3.10x | 3.23x | 2.71x | 1.48x | 1.21x | 2.67x | .88x | 2.55x | ||||||||||||||||||||||
| Forward Price to Sales MRQ | .39x | .31x | .22x | .10x | .15x | .22x | .27x | .29x | .21x | .14x | .05x | .09x | .11x | .11x | .22x | .34x | .41x | .91x | 1.35x | 2.52x | 12.64x | 2.12x | 1.07x | 1.59x | 3.65x | 1.86x | .98x | .85x | 2.64x | 1.29x | 2.34x | ||||||||||||||||||
| Price to Book | 1.24x | .98x | .71x | .21x | .32x | .48x | .57x | .54x | .49x | .31x | .15x | .19x | .25x | .24x | .54x | .54x | .36x | .71x | .92x | .95x | 6.79x | 1.26x | .41x | 1.18x | 9.06x | 1.10x | .35x | .48x | .73x | .25x | 3.24x | ||||||||||||||||||
| Price to Earnings | - | - | - | 4.40x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||||
| Forward Price to Earnings MRQ | - | - | - | .45x | 3.08x | 2.45x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.46x | - | - | ||||||||||||||||||
| Debt to Asset Ratio | .85x | .72x | .74x | .74x | .77x | .76x | .75x | .76x | .71x | .72x | .68x | .68x | .68x | .64x | .53x | .51x | .48x | .47x | .32x | .36x | .46x | .77x | .93x | .58x | .53x | .44x | .36x | .45x | .84x | .70x | .73x | .46x | .51x | .87x | .59x | .20x | .37x | .37x | .14x | 4.95x | .55x | 3.67x | 27.26x | 18.62x | |||||
| Current Ratio | 1.26x | 1.03x | .99x | .85x | 1.11x | 1.08x | 1.06x | .92x | 1.05x | 1.02x | .93x | .97x | .87x | .91x | .96x | 1.20x | 3.58x | 3.04x | 1.98x | 1.15x | 1.96x | 4.10x | 4.72x | 1.92x | 2.79x | 3.36x | 1.61x | 2.78x | .84x | 1.32x | 1.17x | .73x | 1.00x | 3.26x | 4.55x | 6.36x | 5.44x | .17x | .54x | .19x | - | - | |||||||